RxNorm Semantic Concepts Index - 291
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "291".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2910 | CKBB - Creatine kinase BB isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2910 | CKBB - Creatine kinase BB isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2910 | CKBB - Creatine kinase BB isoenzyme | Designated preferred name (PT) | NO | |
| RxCUI: 2910 | CKBB - Creatine kinase BB isoenzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 2910 | CKBB - Creatine kinase BB isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29105 | Messenger ribonucleic acid guanylyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29105 | Messenger ribonucleic acid guanylyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 29105 | Messenger ribonucleic acid guanylyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 2911 | Creatine kinase MB isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2911 | Creatine kinase MB isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2911 | Creatine kinase MB isoenzyme | Designated preferred name (PT) | NO | |
| RxCUI: 2911 | Creatine kinase MB isoenzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 2911 | Creatine kinase MB isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29115 | Maalox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2912 | CKMM - Creatine kinase MM isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2912 | CKMM - Creatine kinase MM isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2912 | CKMM - Creatine kinase MM isoenzyme | Designated preferred name (PT) | NO | |
| RxCUI: 2912 | CKMM - Creatine kinase MM isoenzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 2912 | CKMM - Creatine kinase MM isoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 291204 | Tacalcitol | Full form of descriptor (FN) | NO | |
| RxCUI: 291204 | Tacalcitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 291204 | Tacalcitol | Designated preferred name (PT) | NO | |
| RxCUI: 291204 | Tacalcitol | Full form of descriptor (FN) | NO | |
| RxCUI: 291204 | Tacalcitol | Designated preferred name (PT) | NO | |
| RxCUI: 29127 | Macroamylase | Designated preferred name (PT) | NO | |
| RxCUI: 29127 | Macroamylase | Full form of descriptor (FN) | NO | |
| RxCUI: 2913 | creatinine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 29144 | Madopar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 29145 | Maduramicin | Designated preferred name (PT) | NO | |
| RxCUI: 29145 | Maduramicin | Full form of descriptor (FN) | NO | |
| RxCUI: 2915 | Creosote | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2915 | Creosote | Designated preferred name (PT) | YES | |
| RxCUI: 2915 | Creosote | Full form of descriptor (FN) | YES | |
| RxCUI: 2915 | Creosote | Designated preferred name (PT) | YES | |
| RxCUI: 2915 | Creosote | Full form of descriptor (FN) | YES | |
| RxCUI: 29151 | magaldrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 29151 | magaldrate | Designated preferred name (PT) | YES | |
| RxCUI: 29151 | magaldrate | Full form of descriptor (FN) | YES | |
| RxCUI: 29151 | magaldrate | Designated preferred name (PT) | YES | |
| RxCUI: 29151 | magaldrate | Full form of descriptor (FN) | YES | |
| RxCUI: 29155 | magnesium carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 29155 | magnesium carbonate | Designated preferred name (PT) | YES | |
| RxCUI: 29155 | magnesium carbonate | Full form of descriptor (FN) | YES | |
| RxCUI: 29155 | magnesium carbonate | Designated preferred name (PT) | YES | |
| RxCUI: 29155 | magnesium carbonate | Full form of descriptor (FN) | YES | |
| RxCUI: 29164 | magnesium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29170 | magnesium trisilicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 29170 | magnesium trisilicate | Designated preferred name (PT) | YES | |
| RxCUI: 29170 | magnesium trisilicate | Full form of descriptor (FN) | YES | |
| RxCUI: 29170 | magnesium trisilicate | Designated preferred name (PT) | YES | |
| RxCUI: 29170 | magnesium trisilicate | Full form of descriptor (FN) | YES | |
| RxCUI: 29186 | Pyruvic-malic carboxylase | Designated preferred name (PT) | NO | |
| RxCUI: 29186 | Pyruvic-malic carboxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 29186 | Pyruvic-malic carboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29187 | Malate dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) | Designated preferred name (PT) | NO | |
| RxCUI: 29187 | Malate dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29187 | Malate dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) | Full form of descriptor (FN) | NO | |
| RxCUI: 29188 | Malate dehydrogenase oxaloacetate-decarboxylating (nicotinamide adenine dinucleotide phosphate ^+^) | Designated preferred name (PT) | NO | |
| RxCUI: 29188 | Malate dehydrogenase oxaloacetate-decarboxylating (nicotinamide adenine dinucleotide phosphate ^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29188 | Malate dehydrogenase oxaloacetate-decarboxylating (nicotinamide adenine dinucleotide phosphate ^+^) | Full form of descriptor (FN) | NO | |
| RxCUI: 29190 | Malate oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 29190 | Malate oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 29196 | Maleate hydratase | Designated preferred name (PT) | NO | |
| RxCUI: 29196 | Maleate hydratase | Full form of descriptor (FN) | NO |